Volume 12 Number 7/8 July/August 2011
1 August 2011. Related: Editorial.
2011
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention 17-20 July 2011, Rome
1 August 2011. Related: Conference reports.
Webcasts for major research at IAS
1 August 2011. Related: Conference reports.
Treatment is prevention: ARV treatment in HPTN-052 reduces transmission by at least 96%: single transmission in treatment arm occurred before viral suppression
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Daily oral tenofovir/FTC PrEP reduces heterosexual transmission by 63% in the TDF2 study
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Tenofovir/FTC vs tenofovir as daily oral PrEP: preliminary results from Partners PrEP
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Elvitegravir vs raltegravir: 48 week results in treatment-experienced patients
1 August 2011. Related: Conference reports, Antiretrovirals.
Dolutegravir: 48 week results from phase II study in treatment-naive patients
1 August 2011. Related: Conference reports, Antiretrovirals.
Lersivirine: 48 week results compared to efavirenz in phase 2 treatment-naive study
1 August 2011. Related: Conference reports, Antiretrovirals.
Maraviroc plus atazanavir/r without nukes versus standard of care: 48 week results
1 August 2011. Related: Conference reports, Antiretrovirals.
SPARTAC trial: treatment in primary infection for 48 weeks shows small delay in disease progression
1 August 2011. Related: Conference reports, Antiretrovirals.
Hearing loss not associated with HIV in MACS and WIHS cohorts
1 August 2011. Related: Conference reports, Side effects, Coinfections and complications.
Pharmacokinetics of darunavir and fosamprenavir in pregnancy
1 August 2011. Related: Conference reports, Pregnancy, PK and drug interactions.
Low birth weight and preterm delivery
1 August 2011. Related: Conference reports, Pregnancy.
Hormonal contraception and HIV transmission risk
1 August 2011. Related: Conference reports, Pregnancy.
No difference in AIDS-free survival in children starting ART with a CD4% between 15%24% compared to deferring until less than 15% in the PREDICT trial
1 August 2011. Related: Conference reports, Paediatric care.
Paediatric antiretroviral pipeline: update on etravirine and maraviroc
1 August 2011. Related: Conference reports, Paediatric care.
Prematurity not associated with early mortality in infants on ART
1 August 2011. Related: Conference reports, Paediatric care.
More metabolic abnormalities in children receiving a PI compared to NNRTI in NEVEREST study
1 August 2011. Related: Conference reports, Paediatric care, Side effects.
Free online resource for treatment decisions without access to genotype resistance tests
1 August 2011. Related: Conference reports, Drug resistance.
17th Annual Conference of the British HIV Association (BHIVA) 6-8 April 2011, Bournemouth
1 August 2011. Related: Conference reports.
Treatment in seroconversion maintains HIV specific immune responses similar to long term slow progressors
1 August 2011. Related: Conference reports, Treatment strategies, Basic science and immunology.
18th Conference on Retroviruses and Opportunistic Infections (CROI) 27 February-3 March 2011, Boston
1 August 2011. Related: Conference reports.
Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110/ESTER trials
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
DART: high rates of viral suppression after five years and a single CD4 test with a threshold of 250 cells/mm3 could reduce unnecessary switching
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
Lopinavir/r monotherapy used as second-line therapy in resource-limited settings
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST
1 August 2011. Related: Conference reports, Pregnancy, Paediatric care.
Lopinavir/ritonavir oral solution toxicity in neonates
1 August 2011. Related: Conference reports, Paediatric care, Side effects.
Paediatric antiretroviral pipeline: darunavir and raltegravir
1 August 2011. Related: Conference reports, Antiretrovirals, Paediatric care.
FDA approve new NNRTI rilpivirine (Edurant) in the US
1 August 2011. Related: Antiretrovirals.
Gilead signs up for Medicines Patent Pool
1 August 2011. Related: Treatment access.
FDA approve new NNRTI-based fixed dose combination of rilpivirine/tenofovir/FTC (Complera) in the US
1 August 2011. Related: Antiretrovirals.
FDA approval of generic ARVs
1 August 2011. Related: Treatment access.
FDA approve boceprevir (Victrelis) for HCV
1 August 2011. Related: Hepatitis coinfection.
FDA approve telaprevir (Incivek) to treat hepatitis C
1 August 2011. Related: Hepatitis coinfection.
FDA supplemental information about using boceprevir and telaprevir
1 August 2011. Related: Hepatitis coinfection.
Interactions between multivitamins or acid reducing agents and dolutegravir (S/GSK1349572)
1 August 2011. Related: PK and drug interactions.
HPTN 052 study stopped early: significant reduction in HIV transmission from early use of HIV treatment in serodifferent partners
1 August 2011. Related: HIV prevention and transmission.
Lopinavir and rifampicin interaction in HIV-positive patients
1 August 2011. Related: PK and drug interactions.
Case report: Cushings syndrome with atazanavir/ritonavir
1 August 2011. Related: PK and drug interactions.
HTB supplement: 2011 pipeline report
1 August 2011. Related: Special reports.
Treatment as prevention: online presentations
1 August 2011. Related: On the web.
CCR5 tropism guidelines
1 August 2011. Related: On the web.
UN High Level Meeting on HIV and AIDS
1 August 2011. Related: On the web.
Pharmacokinetics of different rifabutin dosing strategies with lopinavir/ritonavir-based ART
1 August 2011. Related: Conference reports, PK and drug interactions, TB coinfection.
Initiation of ART during breastfeeding can induce multidrug resistance in infants
1 August 2011. Related: Conference reports, Pregnancy.
Volume 12 Number 7/8 July/August 2011 PDF
1 August 2011. Related: PDFs.
HTB supplement: 2011 pipeline report
15 July 2011. Related: Editorial.
Introduction and executive summary
14 July 2011. Related: Editorial, Pipeline report.
HIV point of care diagnostics pipeline
14 July 2011. Related: Pipeline report, Diagnostics.
The tuberculosis treatment pipeline
14 July 2011. Related: Pipeline report, TB coinfection.
The hepatitis C treatment pipeline
14 July 2011. Related: Pipeline report, Hepatitis coinfection.
Acknowledgments
14 July 2011. Related: Editorial, Pipeline report.
Dedication
14 July 2011. Related: Editorial, Pipeline report.
The paediatric antiretroviral pipeline
14 July 2011. Related: Pipeline report, Paediatric care.
The antiretroviral pipeline
14 July 2011. Related: Pipeline report, Antiretrovirals.
Preventive technologies, immune-based and gene therapies, and research towards a cure
14 July 2011. Related: HIV prevention and transmission, Basic science and immunology, Vaccines and microbicides.
The tuberculosis diagnostic pipeline
14 July 2011. Related: Pipeline report, TB coinfection.
The tuberculosis vaccine pipeline
14 July 2011. Related: Pipeline report, TB coinfection.
Patents and the pipeline: is access under threat?
14 July 2011. Related: Pipeline report, Treatment access.
2011 pipeline report PDF
13 July 2011. Related: Pipeline report, PDFs.
Volume 13 Number 5/6 May/June 2011
13 May 2011. Related: Editorial.
Job vacancy: Treatment activist post at i-Base
13 May 2011. Related: Other news.
First Workshop on Nanomedicine for Infectious Diseases of Poverty, 27-31 March 2011, Magaliesberg, South Africa
10 May 2011. Related: Conference reports.
17th Annual Conference of the British HIV Association (BHIVA), 6-8 April 2011, Bournemouth
1 May 2011. Related: Conference reports.